ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target

Chemically modified antisense oligonucleotide against ARL4C inhibits primary and metastatic liver tumor growth

(2019) Takeshi Harada et al.   MOLECULAR CANCER THERAPEUTICS

Knockdown of ARL4C inhibits osteogenic differentiation of human adipose-derived stem cells through disruption of the Wnt signaling pathway

(2018) Wensi Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers

(2018) Shiro Wakinoue et al.   Cancer Biomarkers

ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma

(2018) Qian Chen et al.   JOURNAL OF PATHOLOGY

ADP-ribosylation factor–like 4C binding to filamin-A modulates filopodium formation and cell migration

(2017) Tsai-Shin Chiang et al.   MOLECULAR BIOLOGY OF THE CELL

Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt–β-catenin and growth factor–Ras signalling

(2016) Shinji Matsumoto et al.   JOURNAL OF BIOCHEMISTRY

Classification and Pathology of Lung Cancer

(2016) Min Zheng   Surgical Oncology Clinics of North America

Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma

(2016) Shinsuke Fujii et al.   Oncotarget

Glycoproteomic Approach Identifies KRAS as a Positive Regulator of CREG1 in Non-small Cell Lung Cancer Cells

(2016) David J. Clark et al.   Theranostics

FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review

(2016) D. Groheux et al.   Diagnostic and Interventional Imaging

A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures

(2014) S. Matsumoto et al.   EMBO JOURNAL

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target

(2014) S Fujii et al.   ONCOGENE

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

(2014) D. A. E. Cross et al.   Cancer Discovery

Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer

(2013) Takeshi Isobe et al.   Journal of Thoracic Oncology

A novel platform to enable inhaled naked RNAi medicine for lung cancer

(2013) Yu Fujita et al.   Scientific Reports

Oncogene-Mediated Human Lung Epithelial Cell Transformation Produces Adenocarcinoma Phenotypes In Vivo

(2011) K. Sasai et al.   CANCER RESEARCH

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer

(2011) Rodrigo Dienstmann et al.   Molecular Oncology

Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells

(2011) Pierre Mordant et al.   PLoS One

Intratracheally Administered 5-Azacytidine Is Effective Against Orthotopic Human Lung Cancer Xenograft Models and Devoid of Important Systemic Toxicity

(2010) Sameer Mahesh et al.   Clinical Lung Cancer

ADP-ribosylation factor like 7 (ARL7) interacts with α-tubulin and modulates intracellular vesicular transport

(2009) Shu-mei Wei et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

(2009) A F Gazdar   ONCOGENE

Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: Comparison with solitary ground-glass opacity nodule

(2008) Tae Jung Kim et al.   LUNG CANCER

Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug

(2008) Olga B. Garbuzenko et al.   PHARMACEUTICAL RESEARCH